谷歌浏览器插件
订阅小程序
在清言上使用

Predictors of Progression Free Survival, Overall Survival and Early Cessation of Chemotherapy in Women with Potentially Platinum Sensitive (PPS) Recurrent Ovarian Cancer (ROC) Starting Third or Subsequent Line(≥3) Chemotherapy – the GCIG Symptom Benefit Study (SBS)

Gynecologic Oncology(2019)

引用 8|浏览100
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要